No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan

被引:31
作者
Huang, Wen-Kuan [1 ]
Chiou, Meng-Jiun [2 ]
Kuo, Chang-Fu [3 ]
Lin, Yung-Chang [1 ]
Yu, Kuang-Hui [3 ]
See, Lai-Chu [2 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Div Hematol Oncol,Dept Internal Med, Taoyuan, Taiwan
[2] Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan 333, Taiwan
[3] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Div Rheumatol Allergy & Immunol,Dept Internal Med, Taoyuan, Taiwan
[4] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan
关键词
Rheumatoid arthritis; Cancer; Cohort study; Standardized incidence ratio; LYMPHOMA RISK; MALIGNANCY; MORTALITY; EXPOSURE;
D O I
10.1007/s00296-014-2982-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The association between rheumatoid arthritis (RA) and cancer is still controversial. This study aimed to estimate cancer incidence (both overall and site-specific) among patients with RA and to determine whether their cancer risk was higher than in the general population. We used the nationwide dynamic cohort from the National Health Insurance Research Database of Taiwan and obtained a total of 30,504 patients with no history of cancer who were newly diagnosed with RA between 1996 and 2008; they were followed up until 2010. Standardized incidence ratios (SIR) by age for various types of cancer were calculated in 5-year calendar periods by 5-year age intervals (quinquinquennium) to compare elevated risk of increasing age and increased cancer rate in later calendar years in Taiwan. During 225,432 person-years of follow-up, 1,595 cancers occurred, corresponding to 7.08 per 1,000 person-years. The SIR for all cancers was 0.93 (95 % CI 0.88-0.97). Most cancers were found in the first 2 years after diagnosis of RA, but the incidence decreased afterward. A significant excess of Hodgkin's lymphoma (SIR 3.31, 95 % CI 1.24-8.81) and non-Hodgkin's lymphoma (SIR 3.18, 95 % CI 2.64-3.83) was seen among patients with RA, whereas the risk of colorectal cancer was 29 % lower than the general population. In conclusion, this study showed that patients with RA do not have increased overall risk of cancers but have higher risk of hematologic malignancies and lower risk of colorectal cancer, than the general population.
引用
收藏
页码:1379 / 1386
页数:8
相关论文
共 40 条
[1]   Cancer in rheumatoid arthritis:: Occurrence, mortality, and associated factors in a South European population [J].
Abasolo, Lydia ;
Judez, Enrique ;
Descalzo, Miguel Angel ;
Gonzalez-Alvaro, Isidoro ;
Jover, Juan Angel ;
Carmona, Loreto .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (06) :388-397
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Baecklund, E ;
Brandt, L ;
Backlin, C ;
Ekbom, A ;
Sundström, C ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L ;
Feltelius, N .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420
[4]   Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Brandt, L ;
Baecklund, E ;
Bertilsson, L ;
Feltelus, N ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1421-1426
[5]   Rheumatoid arthritis and malignant lymphomas [J].
Baecklund, E ;
Askling, J ;
Rosenquist, R ;
Ekbom, A ;
Klareskog, L .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) :254-261
[6]   Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis [J].
Baecklund, E ;
Iliadou, A ;
Askling, J ;
Ekborn, A ;
Backlin, C ;
Granath, F ;
Catrina, AT ;
Rosenquist, R ;
Feltelius, N ;
Sundström, C ;
Klareskog, L .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :692-701
[7]   MALIGNANCY FOLLOWING TREATMENT OF RHEUMATOID-ARTHRITIS WITH CYCLOPHOSPHAMIDE - LONG-TERM CASE-CONTROL FOLLOW-UP-STUDY [J].
BAKER, GL ;
KAHL, LE ;
ZEE, BC ;
STOLZER, BL ;
AGARWAL, AK ;
MEDSGER, TA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) :1-9
[8]   The incidence of cancer associated with the treatment of rheumatoid arthritis [J].
Beauparlant, P ;
Papp, K ;
Haraoui, B .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (03) :148-158
[9]   Hematologic Malignant neoplasms after drug exposure in rheumatoid arthritis [J].
Bernatsky, Sasha ;
Clarke, Ann E. ;
Suissa, Samy .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (04) :378-381
[10]   Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate [J].
Bologna, C ;
Picot, MC ;
Jorgensen, C ;
Viu, P ;
Verdier, R ;
Sany, J .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (02) :97-102